COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 384: Articles 3831-3840  | Next

Phylogeny and evolution of the SARS-CoV-2 spike gene from December 2022 to February 2023
Kao, H.-W., Kao, H.-W.
10.1101/2023.07.23.549423 — Posted: 2023-07-24
Comparison of the analytical and clinical sensitivity of thirty-four rapid antigen tests with the most prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UK
Byrne, R. L., Aljayyoussi, G., Greenland - Bews, C., Kontogianni, K., Wooding, D., Williams, C. T., de Vos, M., Body, R., Adams, E. R., Escadafel, C., Edwards, T. R., Cubas Atienzar, A. I.
10.1101/2023.07.24.23293072 — Posted: 2023-07-24
Incubation-period estimates of Omicron (BA.1) variant from Taiwan, December 2021-January 2022, and its comparison to other SARS-CoV-2 variants: a statistical modeling, systematic search and meta-analysis
Akhmetzhanov, A. R., Cheng, H.-Y., Dushoff, J.
10.1101/2023.07.20.23292983 — Posted: 2023-07-24
Temporal changes in the positivity rate of common enteric viruses among paediatric admissions in coastal Kenya, in the period spanning the COVID-19 pandemic, 2019-2022
LAMBISIA, A. W., Murunga, N., Mutunga, M., Cheruiyot, R., Maina, G., MAKORI, T. O., Nokes, D. J., Agoti, C. N.
10.1101/2023.07.24.23293059 — Posted: 2023-07-24
Impact of Emerging COVID-19 variants on psychosocial health: A Systematic Review
Kumar, P., Sarkar, M., Yurkina, M. F., Gnanaraj, R., Martinez, D. J. G., Pisfil-Farronay, Y. A., Chaudhary, L., Agrawal, P., Kaushal, G. P., Mbwogge, M., Abhishek, K., Alnaasan, M., Arlettaz, M. E., Kozum, R., Moyron, M. F. J., Panchawagh, S., Reddy, A. P., Unnithan, V. B.
10.1101/2023.07.23.23293040 — Posted: 2023-07-24
Mental health status and related factors influencing healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis
Huang, J., Huang, Z., Sun, X., Chen, T., Wu, X.
10.1101/2023.07.21.23292948 — Posted: 2023-07-24
Reactivation of herpesvirus type-6 and IgA/IgM-mediated responses to activin-A underpin Long COVID, including affective symptoms and chronic fatigue syndrome.
Vojdani, A., Almulla, A. F., Zhou, B., Al-Hakeim, H. F., Maes, M.
10.1101/2023.07.23.23293046 — Posted: 2023-07-24
The Political Division toward COVID-19, Vaccines, Contact Tracing Apps, and A Future Pandemic Scenario in the United States: A Survey Result from A National Representative Sample
Hao, H., Smith, G., Chen, Y., Mondal, M., Loh, P.-S., Smith, S., Page, X.
10.1101/2023.07.20.23292950 — Posted: 2023-07-24
Protective role of N-acetylcysteine and Sulodexide on endothelial cells after SARS-CoV-2 infection
Rajewska-Tabor, J., Sosinska, P., Pyda, M., Breborowicz, A.
10.1101/2023.07.19.549800 — Posted: 2023-07-24
Worldwide trends in COVID-19 related attacks against healthcare
Duffhues, W., Barten, D., De Cauwer, H., Mortelmans, L., van Osch, F., Tin, D., Koopmans, M., Ciottone, G.
10.1101/2023.07.18.23292819 — Posted: 2023-07-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).